Approximately one month ago, the National Immunization Program introduced the COVID-19
booster – an additional dose administered to increase the body’s immune response, and further
help extend the protection gained from the first two doses.
Approximately one month ago, the National Immunization Program introduced the COVID-19 booster – an additional dose administered to increase the body’s immune response, and further help extend the protection gained from the first two doses. At the time of introduction, only the Pfizer BioNTech vaccine was offered to persons who received their complete regimen of Astrazeneca over 6 months ago. Over the past few weeks, there have been further developments – Astrazeneca COVID-19 Vaccine is now offered as a booster. The WHO supports an extended primary series with an additional vaccine dose for COVID-19 vaccination especially for individuals with immunocompromising conditions. While the booster is recommended for the high-risk population, other individuals can come forward for the booster dose. To date 1309 Booster doses have been administered.
See full press release in PDF link below.
